DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Haefeli WE, Blank A, Mikus G, Mier W, Alexandrov A, Urban S.
Successful first administration of Myrcludex B, a first-in-class hepatitis B and D virus entry inhibitor, in humans.
Hepatology 2012;
56: 372A
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.